IBB · iShares Biotechnology ETF
United States · RS rating 90 · As of 2026-10-14
| Price | 203.25 USD |
|---|---|
| 1-day change | +1.6% |
| RS rating (overall / 1M / 3M / 12M) | 90 / 74 / 83 / 84 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 40 / 44 / 32 |
| Industry group (rank) | Finance-ETF / ETN (48) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +6.3% |
| Market cap (USD) | $12.0B |